Rocket One Inc. Unrealized Gain (Loss) on Derivatives
Rocket One Inc. (RKTO) reported Unrealized Gain (Loss) on Derivatives of $119.87 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivatives · last filed 2023-03-31
- Rocket One Inc. unrealized gain (loss) on derivatives for the quarter ending 2022-12-31 was $251.93K.
- Rocket One Inc. unrealized gain (loss) on derivatives for the quarter ending 2022-09-30 was $26.57K, a 177.78% increase year-over-year.
- Rocket One Inc. unrealized gain (loss) on derivatives for the quarter ending 2022-06-30 was -$180.58K.
- Rocket One Inc. unrealized gain (loss) on derivatives for the quarter ending 2022-03-31 was $21.95K.
- Rocket One Inc. unrealized gain (loss) on derivatives for fiscal 2022 was $119.87K.
- Rocket One Inc. unrealized gain (loss) on derivatives for fiscal 2021 was -$176.97K, a 450.08% decline from fiscal 2020.
- Rocket One Inc. unrealized gain (loss) on derivatives for fiscal 2020 was $50.55K.
| Period end | Unrealized Gain (Loss) on Derivatives 3 month | Unrealized Gain (Loss) on Derivatives 6 month | Unrealized Gain (Loss) on Derivatives 9 month | Unrealized Gain (Loss) on Derivatives 12 month |
|---|---|---|---|---|
| 2022-12-31 | $251.93K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $278.50K derived: sum of 2 quarters · filed 2023-03-31 | $97.92K derived: sum of 3 quarters · filed 2023-03-31 | $119.87K 10-K · filed 2023-03-31 |
| 2022-09-30 | $26.57K 10-Q · filed 2022-11-10 | -$154.01K derived: sum of 2 quarters · filed 2022-11-10 | -$132.06K 10-Q · filed 2022-11-10 | -$271.19K derived: sum of 4 quarters · filed 2023-03-31 |
| 2022-06-30 | -$180.58K 10-Q · filed 2022-08-12 | -$158.63K 10-Q · filed 2022-08-12 | -$297.76K derived: sum of 3 quarters · filed 2023-03-31 | -$288.20K derived: sum of 4 quarters · filed 2023-03-31 |
| 2022-03-31 | $21.95K 10-Q · filed 2022-05-12 | -$117.18K derived: sum of 2 quarters · filed 2023-03-31 | -$107.62K derived: sum of 3 quarters · filed 2023-03-31 | -$137.09K derived: sum of 4 quarters · filed 2023-03-31 |
| 2021-12-31 | -$139.13K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$129.56K derived: sum of 2 quarters · filed 2023-03-31 | -$159.04K derived: sum of 3 quarters · filed 2023-03-31 | -$176.97K 10-K · filed 2023-03-31 |
| 2021-09-30 | $9.57K 10-Q · filed 2022-11-10 | -$19.91K derived: sum of 2 quarters · filed 2022-11-10 | -$37.84K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | -$29.48K 10-Q · filed 2022-08-12 | -$47.41K 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | -$17.93K 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | $50.55K 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |